474 related articles for article (PubMed ID: 31926238)
1. Surface display of uropathogenic Escherichia coli FimH in Lactococcus lactis: In vitro characterization of recombinant bacteria and its protectivity in animal model.
Derakhshandeh S; Shahrokhi N; Khalaj V; Habibi M; Moazzezy N; Asadi Karam MR; Bouzari S
Microb Pathog; 2020 Apr; 141():103974. PubMed ID: 31926238
[TBL] [Abstract][Full Text] [Related]
2. Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice.
Asadi Karam MR; Oloomi M; Mahdavi M; Habibi M; Bouzari S
Vaccine; 2013 Feb; 31(8):1210-6. PubMed ID: 23306365
[TBL] [Abstract][Full Text] [Related]
3. In Vivo Consumption of Cranberry Exerts ex Vivo Antiadhesive Activity against FimH-Dominated Uropathogenic Escherichia coli: A Combined in Vivo, ex Vivo, and in Vitro Study of an Extract from Vaccinium macrocarpon.
Rafsanjany N; Senker J; Brandt S; Dobrindt U; Hensel A
J Agric Food Chem; 2015 Oct; 63(40):8804-18. PubMed ID: 26330108
[TBL] [Abstract][Full Text] [Related]
4. Construction and development of FimH lectin domain for rising immune response after injection by uropathogenic E. coli.
Zandi M; Fallah Mehrabadi J; Mahdavi M; Irani S
Hum Antibodies; 2020; 28(2):169-178. PubMed ID: 32116244
[TBL] [Abstract][Full Text] [Related]
5. Intranasal immunization with fusion protein MrpH·FimH and MPL adjuvant confers protection against urinary tract infections caused by uropathogenic Escherichia coli and Proteus mirabilis.
Habibi M; Asadi Karam MR; Shokrgozar MA; Oloomi M; Jafari A; Bouzari S
Mol Immunol; 2015 Apr; 64(2):285-94. PubMed ID: 25562574
[TBL] [Abstract][Full Text] [Related]
6. Transurethral instillation with fusion protein MrpH.FimH induces protective innate immune responses against uropathogenic Escherichia coli and Proteus mirabilis.
Habibi M; Asadi Karam MR; Bouzari S
APMIS; 2016 Jun; 124(6):444-52. PubMed ID: 26918627
[TBL] [Abstract][Full Text] [Related]
7. Selective depletion of uropathogenic E. coli from the gut by a FimH antagonist.
Spaulding CN; Klein RD; Ruer S; Kau AL; Schreiber HL; Cusumano ZT; Dodson KW; Pinkner JS; Fremont DH; Janetka JW; Remaut H; Gordon JI; Hultgren SJ
Nature; 2017 Jun; 546(7659):528-532. PubMed ID: 28614296
[TBL] [Abstract][Full Text] [Related]
8. Molecular Analysis of Uropathogenic E.coli Isolates from Urinary Tract Infections.
Valadbeigi H; Esmaeeli E; Ghafourian S; Maleki A; Sadeghifard N
Infect Disord Drug Targets; 2019; 19(3):322-326. PubMed ID: 30421685
[TBL] [Abstract][Full Text] [Related]
9. Luteolin decreases the attachment, invasion and cytotoxicity of UPEC in bladder epithelial cells and inhibits UPEC biofilm formation.
Shen XF; Ren LB; Teng Y; Zheng S; Yang XL; Guo XJ; Wang XY; Sha KH; Li N; Xu GY; Tian HW; Wang XY; Liu XK; Li J; Huang N
Food Chem Toxicol; 2014 Oct; 72():204-11. PubMed ID: 25051393
[TBL] [Abstract][Full Text] [Related]
10. Human Urine Decreases Function and Expression of Type 1 Pili in Uropathogenic Escherichia coli.
Greene SE; Hibbing ME; Janetka J; Chen SL; Hultgren SJ
mBio; 2015 Jun; 6(4):e00820. PubMed ID: 26126855
[TBL] [Abstract][Full Text] [Related]
11. Dimeric and Trimeric Fusion Proteins Generated with Fimbrial Adhesins of Uropathogenic
Luna-Pineda VM; Reyes-Grajeda JP; Cruz-Córdova A; Saldaña-Ahuactzi Z; Ochoa SA; Maldonado-Bernal C; Cázares-Domínguez V; Moreno-Fierros L; Arellano-Galindo J; Hernández-Castro R; Xicohtencatl-Cortes J
Front Cell Infect Microbiol; 2016; 6():135. PubMed ID: 27843814
[TBL] [Abstract][Full Text] [Related]
12. Antiadhesive natural products against uropathogenic E. coli: What can we learn from cranberry extract?
Scharf B; Schmidt TJ; Rabbani S; Stork C; Dobrindt U; Sendker J; Ernst B; Hensel A
J Ethnopharmacol; 2020 Jul; 257():112889. PubMed ID: 32311481
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of adhesin genes and risk factors associated with urinary tract infections by drug-resistant uropathogenic Escherichia coli in North of Iran.
Sheikhi R; Amini ME; Alidoust L; Atrkar Roushan Z; Nikokar I
J Infect Dev Ctries; 2024 May; 18(5):761-769. PubMed ID: 38865401
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the effect of MPL and delivery route on immunogenicity and protectivity of different formulations of FimH and MrpH from uropathogenic Escherichia coli and Proteus mirabilis in a UTI mouse model.
Habibi M; Asadi Karam MR; Bouzari S
Int Immunopharmacol; 2015 Sep; 28(1):70-8. PubMed ID: 26033493
[TBL] [Abstract][Full Text] [Related]
15. Combinatorial small-molecule therapy prevents uropathogenic Escherichia coli catheter-associated urinary tract infections in mice.
Guiton PS; Cusumano CK; Kline KA; Dodson KW; Han Z; Janetka JW; Henderson JP; Caparon MG; Hultgren SJ
Antimicrob Agents Chemother; 2012 Sep; 56(9):4738-45. PubMed ID: 22733070
[TBL] [Abstract][Full Text] [Related]
16. Targeting of Uropathogenic Escherichia coli papG gene using CRISPR-dot nanocomplex reduced virulence of UPEC.
Gupta S; Kumar P; Rathi B; Verma V; Dhanda RS; Devi P; Yadav M
Sci Rep; 2021 Sep; 11(1):17801. PubMed ID: 34493749
[TBL] [Abstract][Full Text] [Related]
17. Positive selection identifies an in vivo role for FimH during urinary tract infection in addition to mannose binding.
Chen SL; Hung CS; Pinkner JS; Walker JN; Cusumano CK; Li Z; Bouckaert J; Gordon JI; Hultgren SJ
Proc Natl Acad Sci U S A; 2009 Dec; 106(52):22439-44. PubMed ID: 20018753
[TBL] [Abstract][Full Text] [Related]
18. Design of a chimeric protein composed of FimH, FyuA and CNF-1 virulence factors from uropathogenic Escherichia coli and evaluation its biological activity and immunogenicity in vitro and in vivo.
Hedayat S; Habibi M; Hosseini Doust R; Asadi Karam MR
Microb Pathog; 2023 Jan; 174():105920. PubMed ID: 36460143
[TBL] [Abstract][Full Text] [Related]
19. Repurposing auranofin to combat uropathogenic Escherichia coli biofilms.
Jang HI; Eom YB
J Appl Microbiol; 2019 Aug; 127(2):459-471. PubMed ID: 31087803
[TBL] [Abstract][Full Text] [Related]
20. Molecular variations in Klebsiella pneumoniae and Escherichia coli FimH affect function and pathogenesis in the urinary tract.
Rosen DA; Pinkner JS; Walker JN; Elam JS; Jones JM; Hultgren SJ
Infect Immun; 2008 Jul; 76(7):3346-56. PubMed ID: 18474655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
